Cytokine Switch and Bystander Suppression of Autoimmune Responses to Multiple Antigens in Experimental Autoimmune Encephalomyelitis by a Single Recombinant T-Cell Receptor Ligand

Documenti analoghi

• Binding of recombinant T cell receptor ligands (RTL) to antigen presenting cells prevents upregulation of CD11b and inhibits T cell activation and transfer of experimental autoimmune encephalomyelitis
  di: Sinha, Sushmita, et al.
  Pubblicazione: (2010)
• A Promising Therapeutic Approach for Multiple Sclerosis: Recombinant T-Cell Receptor Ligands Modulate Experimental Autoimmune Encephalomyelitis by Reducing Interleukin-17 Production and Inhibiting Migration of Encephalitogenic Cells into the CNS
  di: Sinha, Sushmita, et al.
  Pubblicazione: (2007)
• IL-13-Mediated Gender Difference in Susceptibility to Autoimmune Encephalomyelitis
  di: Sinha, Sushmita, et al.
  Pubblicazione: (2008)
• Recombinant T-cell Receptor Ligands: Immunomodulatory, Neuroprotective and Neuroregenerative Effects Suggest Application as Therapy for Multiple Sclerosis
  di: Offner, Halina, et al.
  Pubblicazione: (2008)
• Oestrogen-mediated protection of experimental autoimmune encephalomyelitis in the absence of Foxp3(+) regulatory T cells implicates compensatory pathways including regulatory B cells
  di: Subramanian, Sandhya, et al.
  Pubblicazione: (2011)